Difference between revisions of "Team:Georgia State"
Line 138: | Line 138: | ||
<div class="row text-center"> | <div class="row text-center"> | ||
<div class="col-md-12"> | <div class="col-md-12"> | ||
− | <h3 class="h4" style="text-align: | + | <h3 class="h4" style="text-align: center;color: white;">Our Project</h3> |
<div class="spacer-15"></div> | <div class="spacer-15"></div> | ||
<p class="lead" style="color: white;" ><a class="tipped" data-title="Abstract" data-tipper-options='{"direction":"top"}'><b>Protein Products from Plants and Pichia: Novel Manufacturing of Analgesics and Cannabinoids</b><br></a> Cannabinoids and opiates are widely used classes of pharmaceuticals; unfortunately, these drugs have strong psychoactive effects or can be addictive. Our project consists of two ideas, both revolving around utilizing bioengineered microorganisms to create non-psychoactive cannabinoids and non-addictive analgesics. To achieve this we developed two projects: (1) Manufacturing a protein expression system to produce CBDA synthase in tobacco plants using agrobacterium, (2) Engineering the pGAPα vector system to express the mambalgin in Pichia Pastoris as a continuation of the 2014 GSU iGEM project. Simultaneously, we developed a proof of concept using horseradish peroxidase. By the end of this project we hope to have produced a synthetic biological system to manufacture pharmaceutical alternatives for patients that suffer from diseases such as epilepsy, cancer, or chronic severe pain.</p> | <p class="lead" style="color: white;" ><a class="tipped" data-title="Abstract" data-tipper-options='{"direction":"top"}'><b>Protein Products from Plants and Pichia: Novel Manufacturing of Analgesics and Cannabinoids</b><br></a> Cannabinoids and opiates are widely used classes of pharmaceuticals; unfortunately, these drugs have strong psychoactive effects or can be addictive. Our project consists of two ideas, both revolving around utilizing bioengineered microorganisms to create non-psychoactive cannabinoids and non-addictive analgesics. To achieve this we developed two projects: (1) Manufacturing a protein expression system to produce CBDA synthase in tobacco plants using agrobacterium, (2) Engineering the pGAPα vector system to express the mambalgin in Pichia Pastoris as a continuation of the 2014 GSU iGEM project. Simultaneously, we developed a proof of concept using horseradish peroxidase. By the end of this project we hope to have produced a synthetic biological system to manufacture pharmaceutical alternatives for patients that suffer from diseases such as epilepsy, cancer, or chronic severe pain.</p> |
Revision as of 20:17, 2 September 2015
P4= Protein Products Pichia Plants
Our Project
Protein Products from Plants and Pichia: Novel Manufacturing of Analgesics and Cannabinoids
Cannabinoids and opiates are widely used classes of pharmaceuticals; unfortunately, these drugs have strong psychoactive effects or can be addictive. Our project consists of two ideas, both revolving around utilizing bioengineered microorganisms to create non-psychoactive cannabinoids and non-addictive analgesics. To achieve this we developed two projects: (1) Manufacturing a protein expression system to produce CBDA synthase in tobacco plants using agrobacterium, (2) Engineering the pGAPα vector system to express the mambalgin in Pichia Pastoris as a continuation of the 2014 GSU iGEM project. Simultaneously, we developed a proof of concept using horseradish peroxidase. By the end of this project we hope to have produced a synthetic biological system to manufacture pharmaceutical alternatives for patients that suffer from diseases such as epilepsy, cancer, or chronic severe pain.
Sponsor
![](https://static.igem.org/mediawiki/2015/8/8d/GSUiGEM_biologylogo.png)
![](https://static.igem.org/mediawiki/2015/b/ba/Idt_logo2015.jpg)
![](img/logos/04.png)
![](img/logos/05.png)
![](img/logos/06.png)
![](img/logos/08.png)
![](img/logos/01.png)
![](img/logos/02.png)
![](img/logos/03.png)
Address
502, DieSachbearbeiter, Schönhauser Allee, 167c10435 Berlin,Germany.
Call Us
+40 (0) 012 345 6789
Get Connected With Us
Twitter
Facebook